Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

2 terminated/withdrawn out of 8 trials

Success Rate

71.4%

-15.1% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

Phase 2

2(28.6%)

N/A

2(28.6%)

Phase 1

1(14.3%)

Early Phase 1

1(14.3%)

Phase 3

1(14.3%)

7Total

Phase 2(2)

N/A(2)

Phase 1(1)

Early Phase 1(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06798558Phase 2Recruiting

Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy

Role: collaborator

NCT02846389Not ApplicableTerminated

Trial of Exercise to Reduce Cancer Related Fatigue in Breast Cancer

Role: collaborator

NCT03586596Not ApplicableCompleted

Mobile Cessation Support for Latino Smokers

Role: collaborator

NCT03800758Phase 3Completed

Expressive Helping for Stem Cell Transplant Patients

Role: collaborator

NCT02910219Phase 2Completed

Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients

Role: collaborator

NCT02069080Early Phase 1Terminated

Imaging CXCR4 Expression in Subjects With Cancer Using 64 Cu-Plerixafor

Role: collaborator

NCT00003108Phase 1Completed

Cisplatin Plus Bryostatin 1 in Treating Patients With Advanced Cancer

Role: lead

NCT00582829Completed

Colorectal Cancer Screening Intervention for Family Members of Colorectal Cancer Patients

Role: collaborator

All 8 trials loaded